annual current liabilities:
$106.92M+$57.02M(+114.28%)Summary
- As of today (May 29, 2025), NAMS annual total current liabilities is $106.92 million, with the most recent change of +$57.02 million (+114.28%) on December 31, 2024.
- During the last 3 years, NAMS annual current liabilities has risen by +$95.73 million (+855.79%).
- NAMS annual current liabilities is now at all-time high.
Performance
NAMS Current liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly current liabilities:
$40.91M-$66.00M(-61.73%)Summary
- As of today (May 29, 2025), NAMS quarterly total current liabilities is $40.91 million, with the most recent change of -$66.00 million (-61.73%) on March 31, 2025.
- Over the past year, NAMS quarterly current liabilities has dropped by -$18.81 million (-31.50%).
- NAMS quarterly current liabilities is now -61.73% below its all-time high of $106.92 million, reached on December 31, 2024.
Performance
NAMS quarterly current liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Current liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
NAMS Current liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +114.3% | -31.5% |
| 3 y3 years | +855.8% | +51.2% |
| 5 y5 years | +578.7% | +265.7% |
NAMS Current liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +855.8% | -61.7% | +265.7% |
| 5 y | 5-year | at high | +855.8% | -61.7% | +265.7% |
| alltime | all time | at high | +855.8% | -61.7% | +265.7% |
NAMS Current liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $40.91M(-61.7%) |
| Dec 2024 | $106.92M(+114.3%) | $106.92M(+159.2%) |
| Sep 2024 | - | $41.26M(-8.9%) |
| Jun 2024 | - | $45.31M(-24.1%) |
| Mar 2024 | - | $59.73M(+19.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2023 | $49.90M(+38.4%) | $49.90M(+19.8%) |
| Jun 2023 | - | $41.66M(+15.5%) |
| Dec 2022 | $36.06M(+222.3%) | $36.06M(+33.3%) |
| Jun 2022 | - | $27.06M(+141.9%) |
| Dec 2021 | $11.19M(-29.0%) | $11.19M |
| Dec 2020 | $15.75M | - |
FAQ
- What is NewAmsterdam Pharma Company NV annual total current liabilities?
- What is the all time high annual current liabilities for NewAmsterdam Pharma Company NV?
- What is NewAmsterdam Pharma Company NV annual current liabilities year-on-year change?
- What is NewAmsterdam Pharma Company NV quarterly total current liabilities?
- What is the all time high quarterly current liabilities for NewAmsterdam Pharma Company NV?
- What is NewAmsterdam Pharma Company NV quarterly current liabilities year-on-year change?
What is NewAmsterdam Pharma Company NV annual total current liabilities?
The current annual current liabilities of NAMS is $106.92M
What is the all time high annual current liabilities for NewAmsterdam Pharma Company NV?
NewAmsterdam Pharma Company NV all-time high annual total current liabilities is $106.92M
What is NewAmsterdam Pharma Company NV annual current liabilities year-on-year change?
Over the past year, NAMS annual total current liabilities has changed by +$57.02M (+114.28%)
What is NewAmsterdam Pharma Company NV quarterly total current liabilities?
The current quarterly current liabilities of NAMS is $40.91M
What is the all time high quarterly current liabilities for NewAmsterdam Pharma Company NV?
NewAmsterdam Pharma Company NV all-time high quarterly total current liabilities is $106.92M
What is NewAmsterdam Pharma Company NV quarterly current liabilities year-on-year change?
Over the past year, NAMS quarterly total current liabilities has changed by -$18.81M (-31.50%)